HGH 191AA | HGH191-X (12 IU)

XENE BIOLABS RESEARCH SERIES
FOR RESEARCH USE ONLY

Category: Growth Hormone | Half-life: 20-30 min SubQ, 3.5h IV

Mechanism

Identical to endogenous GH. Binds GH receptor → IGF-1 release, lipolysis, anabolism, glucose regulation.

Dosing Protocol

Reconstitution: 10 IU + 1 mL BAC = 10 IU/mL. 2 IU = 0.2 mL = 20 units.

Critical: Monitor glucose, IGF-1, TSH. Can cause insulin resistance, carpal tunnel, edema at high doses.

HGH 191AA-12X | Full-Spectrum Recombinant HGH | CAS: 12629-01-5

191 Amino Acid recombinant human growth hormone — identical in structure to endogenous GH. Stimulates IGF-1
production, promotes lipolysis, increases lean mass, supports connective tissue, and improves sleep architecture. Unlike
secretagogues, exogenous HGH provides direct GH replacement rather than stimulating pituitary release — suppresses
natural GH axis with chronic use.

DOSING PROTOCOL
ParameterDetails
Bodybuilding / Body Composition2–4 IU/day SubQ
Anti-aging / Wellness1–2 IU/day SubQ
TimingAM fasted; or split AM + post-workout
Cycle Length3–6 months minimum for body composition benefits
Reconstitution

Bacteriostatic water — gentle mixing only

STACKING RECOMMENDATIONS

Stack with IGF-1 LR3 for downstream anabolic amplification. Combine with TRT base (testosterone + primobolan) for lean
recomposition. Add BPC-157 for connective tissue support. Monitor IGF-1 levels.

NOTE: Monitor fasting glucose and IGF-1 (target 200–350 ng/mL). Carpal tunnel syndrome possible at higher doses. Pituitary
suppression with chronic use — cycle with secretagogues.